Rup Kamal Sainju: Clinical Trials

1 trial sponsored by Rup Kamal Sainju, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Rup Kamal Sainju: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
Fluoxetine, Placebo - Epilepsy, SUDEP
Phase 2CompletedRup Kamal Sainju302017-02-162020-05-04

Conditions studied

Epilepsy (1)  ·  Sudden Unexpected Death in Epilepsy (1)

Interventions

Fluoxetine (1)

Countries

United States (1)

Top investigators

Rup Sainju (1)